scholarly journals Co-culture of Spleen Stromal Cells with Bone Marrow Mononuclear Cells Leads to the Generation of A Novel Macrophage Subset

2013 ◽  
Vol 79 (1) ◽  
pp. 27-36 ◽  
Author(s):  
X. Wang ◽  
Y. Li ◽  
H. Xiao ◽  
X. Zhang ◽  
J. Cao ◽  
...  
Cytotherapy ◽  
2008 ◽  
Vol 10 (5) ◽  
pp. 460-468 ◽  
Author(s):  
A. Casado-Díaz ◽  
R. Santiago-Mora ◽  
R. Jiménez ◽  
J. Caballero-Villarraso ◽  
C. Herrera ◽  
...  

Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 3109-3109 ◽  
Author(s):  
Shiho Fujiwara ◽  
Naoko Wada ◽  
Yawara Kawano ◽  
Yoshitaka Kikukawa ◽  
Hiroaki Mitsuya ◽  
...  

Abstract Introduction It has been reported that the growth of certain cancer cells depends on the Warburg effect (aerobic glycolysis) for such cells to adapt to hypoxic environment and obtain ATP efficiently via glycolysis. We have previously reported that genes related to aerobic glycolysis are up-regulated in MM cells, and MM cells produce large amounts of lactate (Br J Cancer 2013, 108, 170-8). In the last ASH meeting, we reported that the expressions of lactate transporters were critical for the survival of MM cells. In this study, we further investigated the roles of lactate transporters in MM cells, focusing on the role of stromal cells as the supplier of lactate in microenvironment. Methods Six MM cell lines, RPMI8226, U266, KMS12BM, KMS12PE, KHM11, and KMM1 were utilized. Bone marrow samples were obtained from newly diagnosed MM patients. Bone marrow mononuclear cells were isolated by Ficoll-Hypaque density sedimentation. To obtain stromal cells, bone marrow mononuclear cells were cultured in RPMI1640 medium supplemented with 10% FCS and allowed to attach to the bottom of plastic wells. After 3-4 weeks incubation, adherent cells were harvested and utilized as stromal cells. The expression of three components of the lactate transporter complex [monocarboxyl transporter 1 (MCT1), MCT4, and CD147] were analyzed with western blotting or flow cytometry. Lactate uptake was quantified using [14C]-Lactate. Cellular ATP production was quanatified with the ATP Determination Kit (Molecular Probes). An inhibitor of MCT1, a-cyano-4 hydroxycinnamic acid (CHC), was utilized to analyze cytotoxic effects on MM cells under both normoxia ( O2 20% ) and hypoxia (O2 1% ). AnnexinV/PI staining was performed to quantify cytotoxicity. Knockdown of MCT1 was achieved using siRNA. Results Knockdown of MCT1, a molecule responsible for lactate incorporation into cytoplasm, induced apoptosis in MM cells, while lactate uptake and ATP production of MM cells were reduced, suggesting that MCT1 inhibition might induce apoptosis in MM cells by decreasing the lactate-derived ATP production. On the other hand, we found significant lactate production by stromal cells. We also found an abundant amount of MCT4, a molecule responsible for lactate excretion, in bone marrow-derived stromal cells. By contrast, lactate amount in the culture supernatant of stromal cells was significantly decreased when they were co-cultured with MM cells. Therefore, it appears that lactate produced by stromal cells is incorporated into MM cells as an energy source. Interestingly, we found that the expression of MCT1 is up-regulated in MM cells under an aerobic condition, while that of MCT4 is up-regulated under a hypoxic condition. The treatment of MM cells with a-cyano-4 hydroxycinnamic acid (CHC), a MCT1 inhibitor, induced apoptosis in MM cells, suggesting that lactate may be more preferentially incorporated into MM cells under a normoxic than hypoxic condition (Figure A). Conclusion Our results suggest that the growth of MM cells, at least in part, depends on lactate under a normoxic condition. The data also suggest that lactate may play a role as an energy interplay shuttle between stromal cells and MM cells (Figure B). Therefore, regulating lactate incorporation by MM cells may provide a new avenue for a therapeutic strategy for multiple myeloma. Disclosures: No relevant conflicts of interest to declare.


Cytotherapy ◽  
2011 ◽  
Vol 13 (10) ◽  
pp. 1193-1204 ◽  
Author(s):  
Zyrafete Kuçi ◽  
Selim Kuçi ◽  
Susanne Zircher ◽  
Stefanie Koller ◽  
Ralf Schubert ◽  
...  

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 1921-1921
Author(s):  
Selim Kuci ◽  
Kathrin Puetsch ◽  
Zyrafete Kuci ◽  
Sabine Huenecke ◽  
Hermann Kreyenberg ◽  
...  

Abstract Mesenchymal stromal cells (MSCs) are non- hematopoietic multipotent cells which can be derived from bone marrow mononuclear cells either by plastic adherence (PA-MSCs) or by a positive selection with antibodies against cell surface antigens expressed by MSC-progenitor cells (CD271, CD73, CD146, CD105, CD166, SSEA-4 and recently GD2). In this study, we compare the phenotype, proliferation potential, differentiation potential, the cytokine expression pattern and inhibitory potential of MSC- derived by plastic adherence and MSCs derived from positively selected CD271+ bone marrow mononuclear cells (BM-MNCs). According to CFU-F assay, the enriched CD271+ BM cells possess a significantly higher frequency (2952 per 1×106 BM cells) compared to PA-MSCs (21 per 1×106 BM cells). Phenotypically, both populations expressed high levels of common MSC antigens such as CD73, CD105, CD44, CD166, CD90, HLA-Class I and were negative for CD34, CD133, and CD14. Compared to PA-MSCs, CD271+ BM cells after the isolation express high levels of the hematopoietic antigen CD45 which is down- regulated within the first passage and HLA-DR, which remains constant through many passages. These cells have a 10- to 1000-fold higher proliferation capacity compared to PA- MSCs. However, both populations differentiated in vitro along adipogenic, chondrogenic and osteogenic lineage. In MLR, both populations significantly suppressed the proliferation of PHA- stimulated allogeneic T- lymphocytes at the ratio 10: 1 (MSCs:T-cells). However, CD271+ BM- derived MSCs were more efficient in secreting IFN-γ, IL-1β, IL-2, IL-4, GM-CSF and TNF-α, whereas PA- MSCs secreted significantly more IL-6 and IL-8 than CD271+ BM- derived MSCs. Ongoing in vivo studies with immunodeficient NOD/SCID mice will show the whole potential of both population in the improvement of engraftment of mobilized peripheral blood hemaatopoietic CD133+ cells. Based on their higher frequency and proliferation capacity we suggest that CD271+ BM- cells may represent a better source than PA- MSCs in order to generate bulk quantities of MSCs for clinical applications.


Sign in / Sign up

Export Citation Format

Share Document